ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 113,68
-0,73%
Dow Jones
43 006,59
1,14%
DAX
23 085,91
-0,15%
Brent Oil
69,295
0,04%
Bitcoin
91 288,38
0,72%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX

  6. Lineage Cell Therapeutics Inc (LCTX) Cours

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc (LCTX)

AMEX
0,5192
-0,0136
(-2,55%)
Fermé 06 Mars 10:00PM
Retardé de 15 minutes
0,514
-0,0052
( -1,00% )
Avant marché: 11:51AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,514
Prix Achat
-
Prix Vente
-
Volume échangé
1 922
0,00 Fourchette du Jour 0,00
0,481 Plage de 52 semaines 1,61
Cap du marché
97,062M
Clôture Veille
0,5192
Ouverture
-
Dernière Transaction
810
@
0.514
(formt)
Dernière heure de transaction
10:20:30
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 895 073
Actions en circulation
188 837 375
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,57
Bénéfice par action (BPA)
-0,11
Chiffre d'affairess
8,95M
Bénéfice net
-21,49M

À propos de Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Line... Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
lineagecell.com
Siège social
Alameda, California, USA
Fondé
-
Lineage Cell Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la American Stock Exchange avec le ticker LCTX. Le dernier cours de clôture d'Lineage Cell Therapeutics était de US$0,52. Au cours de la dernière année, les actions de Lineage Cell Therapeutics ont été négociées dans une fourchette de prix de US$ 0,481 à US$ 1,61.

Lineage Cell Therapeutics compte actuellement 188 837 375 actions en circulation. La capitalisation boursière d'Lineage Cell Therapeutics est de US$98,04 million. Lineage Cell Therapeutics a un ratio cours/bénéfice (ratio PE) de -4.57.

LCTX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 Janvier 2025
LCTX (-2,55%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Janvier 2025
LCTX (-2,55%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
09 Décembre 2024
LCTX (-2,55%)

Form PRE 14A - Other preliminary proxy statements
Edgar (US Regulatory)
29 Novembre 2024
LCTX (-2,55%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 Novembre 2024
LCTX (-2,55%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.1292-20.08706467660.64320.64910.500213604110.53995407CS
4-0.1936-27.36009044660.70760.74990.50029646000.62619821CS
12-0.096-15.7377049180.610.74990.48118950730.57207206CS
26-0.365-41.52445961320.8790.970.48115926620.60831398CS
52-0.586-53.27272727271.11.610.48112135010.7876998CS
156-0.786-60.46153846151.31.790.4817717101.0353429CS
260-0.386-42.88888888890.93.13160.4819021321.47912096CS

LCTX - Frequently Asked Questions (FAQ)

What is the current Lineage Cell Therapeutics share price?
The current share price of Lineage Cell Therapeutics is US$ 0,514
How many Lineage Cell Therapeutics shares are in issue?
Lineage Cell Therapeutics has 188 837 375 shares in issue
What is the market cap of Lineage Cell Therapeutics?
The market capitalisation of Lineage Cell Therapeutics is USD 98,04M
What is the 1 year trading range for Lineage Cell Therapeutics share price?
Lineage Cell Therapeutics has traded in the range of US$ 0,481 to US$ 1,61 during the past year
What is the PE ratio of Lineage Cell Therapeutics?
The price to earnings ratio of Lineage Cell Therapeutics is -4,57
What is the cash to sales ratio of Lineage Cell Therapeutics?
The cash to sales ratio of Lineage Cell Therapeutics is 10,97
What is the reporting currency for Lineage Cell Therapeutics?
Lineage Cell Therapeutics reports financial results in USD
What is the latest annual turnover for Lineage Cell Therapeutics?
The latest annual turnover of Lineage Cell Therapeutics is USD 8,95M
What is the latest annual profit for Lineage Cell Therapeutics?
The latest annual profit of Lineage Cell Therapeutics is USD -21,49M
What is the registered address of Lineage Cell Therapeutics?
The registered address for Lineage Cell Therapeutics is 2173 SALK AVENUE, SUITE 200, ALAMEDA, CALIFORNIA, 92008
What is the Lineage Cell Therapeutics website address?
The website address for Lineage Cell Therapeutics is lineagecell.com
Which industry sector does Lineage Cell Therapeutics operate in?
Lineage Cell Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DXFEason Technology Limited
US$ 9,99
(30,42%)
1,42k
CVRChicago Rivet and Machine Co
US$ 16,00
(16,85%)
2
UVIX2x Long VIX Futures ETF
US$ 39,53
(12,65%)
112,01k
UVXYProShares Ultra VIX Short Term Futures ETF
US$ 24,14
(9,73%)
189,35k
PAPLPineapple Financial Inc
US$ 0,3749
(9,36%)
6
HCWCHealthy Choice Wellness Corp
US$ 0,4716
(-13,23%)
1
CCELCryo Cell International Inc
US$ 6,31
(-11,38%)
109
CVNYYieldmax Cvna Option Income Strategy ETF
US$ 41,61
(-8,59%)
68
FIATYieldmax Short Coin Option Income Strategy ETF
US$ 7,83
(-7,67%)
8,53k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 20,325
(-7,40%)
2,59M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 6,93
(-1,00%)
3,85M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 20,325
(-7,40%)
2,59M
ETHU2x Ether ETF
US$ 3,09
(5,46%)
1,75M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 16,47
(1,67%)
1,48M
FXIiShares China Large Cap
US$ 37,40
(1,66%)
1,11M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

AMEX
LCTX
Lineage Cell Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces